NetScientific plc
("NetScientific" or the "Company")
Results of General Meeting
Further to the announcement on 1 March 2019, NetScientific plc (AIM: NSCI) announces that at the general meeting held earlier today a vote to adjourn the meeting indefinitely was duly passed.
Further announcements will be made as appropriate.
For more information, please contact:
|
NetScientific François R. Martelet, M.D., CEO Ian Postlethwaite, CFO |
Tel: +44 (0)20 3514 1800 |
|
WH Ireland Limited (NOMAD, Financial Adviser and Broker) Chris Fielding / Jessica Cave / Chris Viggor |
Tel: +44 (0)20 7220 1666 |
|
Consilium Strategic Communications Mary-Jane Elliott / Chris Welsh / Laura Thornton NetScientific@consilium-comms.com |
Tel: +44 (0)20 3709 5700 |
About NetScientific
NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases.
For more information, please visit the website at http://www.NetScientific.net
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.